nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—Behcet's disease	0.954	1	CbGaD
Pomalidomide—Thalidomide—TNF—Behcet's disease	0.00493	1	CrCbGaD
Pomalidomide—TNF—Allograft Rejection—MICA—Behcet's disease	0.00182	0.0775	CbGpPWpGaD
Pomalidomide—CRBN—retina—Behcet's disease	0.0016	0.0917	CbGeAlD
Pomalidomide—TNF—amb2 Integrin signaling—ITGB2—Behcet's disease	0.00142	0.0605	CbGpPWpGaD
Pomalidomide—CRBN—mammalian vulva—Behcet's disease	0.00128	0.0734	CbGeAlD
Pomalidomide—CRBN—cardiac atrium—Behcet's disease	0.00123	0.0703	CbGeAlD
Pomalidomide—TNF—IL27-mediated signaling events—STAT4—Behcet's disease	0.00121	0.0515	CbGpPWpGaD
Pomalidomide—CRBN—medulla oblongata—Behcet's disease	0.00116	0.0662	CbGeAlD
Pomalidomide—PTGS2—artery—Behcet's disease	0.00106	0.0607	CbGeAlD
Pomalidomide—CRBN—midbrain—Behcet's disease	0.00106	0.0605	CbGeAlD
Pomalidomide—CRBN—spinal cord—Behcet's disease	0.00103	0.0591	CbGeAlD
Pomalidomide—TNF—IL23-mediated signaling events—STAT4—Behcet's disease	0.000909	0.0388	CbGpPWpGaD
Pomalidomide—PTGS2—endothelium—Behcet's disease	0.000897	0.0513	CbGeAlD
Pomalidomide—CRBN—nervous system—Behcet's disease	0.00087	0.0498	CbGeAlD
Pomalidomide—CRBN—central nervous system—Behcet's disease	0.000838	0.0479	CbGeAlD
Pomalidomide—PTGS2—blood vessel—Behcet's disease	0.000827	0.0473	CbGeAlD
Pomalidomide—ABCB1—Allograft Rejection—MICA—Behcet's disease	0.000796	0.034	CbGpPWpGaD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL10—Behcet's disease	0.000783	0.0335	CbGpPWpGaD
Pomalidomide—TNF—amb2 Integrin signaling—APOB—Behcet's disease	0.000703	0.03	CbGpPWpGaD
Pomalidomide—PTGS2—mouth—Behcet's disease	0.000692	0.0396	CbGeAlD
Pomalidomide—CRBN—brain—Behcet's disease	0.000665	0.038	CbGeAlD
Pomalidomide—TNF—Amyotrophic lateral sclerosis (ALS)—CAT—Behcet's disease	0.000631	0.027	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Behcet's disease	0.000615	0.0263	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—STAT4—Behcet's disease	0.000572	0.0244	CbGpPWpGaD
Pomalidomide—TNF—Overview of nanoparticle effects—CXCL8—Behcet's disease	0.000567	0.0242	CbGpPWpGaD
Pomalidomide—TNF—amb2 Integrin signaling—ICAM1—Behcet's disease	0.000528	0.0226	CbGpPWpGaD
Pomalidomide—ABCB1—blood vessel—Behcet's disease	0.000512	0.0293	CbGeAlD
Pomalidomide—TNF—EBV LMP1 signaling—CXCL8—Behcet's disease	0.000487	0.0208	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—APOB—Behcet's disease	0.000484	0.0207	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—CTLA4—Behcet's disease	0.000427	0.0182	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—CAT—Behcet's disease	0.000406	0.0173	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—APOB—Behcet's disease	0.000394	0.0168	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—APOA1—Behcet's disease	0.000383	0.0164	CbGpPWpGaD
Pomalidomide—PTGS2—skin of body—Behcet's disease	0.000383	0.0219	CbGeAlD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Behcet's disease	0.00038	0.0163	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—ICAM1—Behcet's disease	0.000364	0.0155	CbGpPWpGaD
Pomalidomide—PTGS2—Overview of nanoparticle effects—CXCL8—Behcet's disease	0.000351	0.015	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.000348	0.0149	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL10—Behcet's disease	0.000332	0.0142	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—CAT—Behcet's disease	0.000322	0.0138	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—HLA-B—Behcet's disease	0.000316	0.0135	CbGpPWpGaD
Pomalidomide—PTGS2—medulla oblongata—Behcet's disease	0.000315	0.018	CbGeAlD
Pomalidomide—TNF—Selenium Micronutrient Network—APOB—Behcet's disease	0.000313	0.0134	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—APOA1—Behcet's disease	0.000312	0.0133	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—SERPINE1—Behcet's disease	0.000304	0.013	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—ICAM1—Behcet's disease	0.000296	0.0126	CbGpPWpGaD
Pomalidomide—TNF—Angiopoietin receptor Tie2-mediated signaling—NOS3—Behcet's disease	0.000295	0.0126	CbGpPWpGaD
Pomalidomide—TNF—TGF-beta Receptor Signaling—SERPINE1—Behcet's disease	0.00029	0.0124	CbGpPWpGaD
Pomalidomide—PTGS2—midbrain—Behcet's disease	0.000288	0.0165	CbGeAlD
Pomalidomide—PTGS2—spinal cord—Behcet's disease	0.000281	0.0161	CbGeAlD
Pomalidomide—ABCB1—retina—Behcet's disease	0.00027	0.0154	CbGeAlD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Behcet's disease	0.000262	0.0112	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—APOA1—Behcet's disease	0.000248	0.0106	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—SERPINE1—Behcet's disease	0.000247	0.0106	CbGpPWpGaD
Pomalidomide—PTGS2—Overview of nanoparticle effects—TNF—Behcet's disease	0.000244	0.0104	CbGpPWpGaD
Pomalidomide—PTGS2—nervous system—Behcet's disease	0.000237	0.0136	CbGeAlD
Pomalidomide—TNF—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.000235	0.01	CbGpPWpGaD
Pomalidomide—PTGS2—central nervous system—Behcet's disease	0.000228	0.013	CbGeAlD
Pomalidomide—ABCB1—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.000222	0.00948	CbGpPWpGaD
Pomalidomide—ABCB1—mammalian vulva—Behcet's disease	0.000216	0.0124	CbGeAlD
Pomalidomide—CYP3A4—nervous system—Behcet's disease	0.000207	0.0118	CbGeAlD
Pomalidomide—PTGS2—Selenium Micronutrient Network—CAT—Behcet's disease	0.000199	0.00851	CbGpPWpGaD
Pomalidomide—CYP3A4—central nervous system—Behcet's disease	0.000199	0.0114	CbGeAlD
Pomalidomide—TNF—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.000197	0.00839	CbGpPWpGaD
Pomalidomide—ABCB1—medulla oblongata—Behcet's disease	0.000195	0.0112	CbGeAlD
Pomalidomide—PTGS2—Selenium Micronutrient Network—APOB—Behcet's disease	0.000194	0.00827	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL10—Behcet's disease	0.000193	0.00822	CbGpPWpGaD
Pomalidomide—CYP1A2—Tryptophan metabolism—CAT—Behcet's disease	0.00019	0.0081	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CTLA4—Behcet's disease	0.000187	0.00799	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—ICAM1—Behcet's disease	0.000186	0.00795	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—CXCL8—Behcet's disease	0.000181	0.00775	CbGpPWpGaD
Pomalidomide—PTGS2—brain—Behcet's disease	0.000181	0.0104	CbGeAlD
Pomalidomide—ABCB1—midbrain—Behcet's disease	0.000178	0.0102	CbGeAlD
Pomalidomide—ABCB1—spinal cord—Behcet's disease	0.000174	0.00995	CbGeAlD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Behcet's disease	0.000162	0.00691	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—APOA1—Behcet's disease	0.000153	0.00654	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—CXCL8—Behcet's disease	0.000148	0.00632	CbGpPWpGaD
Pomalidomide—ABCB1—nervous system—Behcet's disease	0.000147	0.00838	CbGeAlD
Pomalidomide—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	0.000146	0.00625	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.000145	0.00621	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL10—Behcet's disease	0.000145	0.00621	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—SERPINE1—Behcet's disease	0.000144	0.00614	CbGpPWpGaD
Pomalidomide—ABCB1—central nervous system—Behcet's disease	0.000141	0.00807	CbGeAlD
Pomalidomide—ABCB1—Allograft Rejection—HLA-B—Behcet's disease	0.000138	0.00591	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—CXCL8—Behcet's disease	0.000132	0.00562	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.000122	0.00519	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.00012	0.00514	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—Behcet's disease	0.000115	0.00493	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—ICAM1—Behcet's disease	0.000115	0.00491	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Behcet's disease	0.000113	0.00481	CbGpPWpGaD
Pomalidomide—ABCB1—brain—Behcet's disease	0.000112	0.00641	CbGeAlD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.000108	0.00463	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—CXCL8—Behcet's disease	0.000105	0.0045	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CXCL8—Behcet's disease	8.14e-05	0.00348	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	7.95e-05	0.0034	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—TNF—Behcet's disease	7.16e-05	0.00306	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	6.81e-05	0.00291	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	6.81e-05	0.00291	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—Behcet's disease	5.67e-05	0.00242	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—Behcet's disease	5.54e-05	0.00236	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	4.35e-05	0.00186	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	3.85e-05	0.00165	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	3.44e-05	0.00147	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	2.93e-05	0.00125	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	2.73e-05	0.00117	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	2.46e-05	0.00105	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.32e-05	0.00099	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOB—Behcet's disease	2.31e-05	0.000987	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—Behcet's disease	1.99e-05	0.000852	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	1.95e-05	0.000831	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOB—Behcet's disease	1.94e-05	0.000827	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOA1—Behcet's disease	1.83e-05	0.000781	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOA1—Behcet's disease	1.53e-05	0.000654	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SERPINE1—Behcet's disease	1.45e-05	0.00062	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—Behcet's disease	1.41e-05	0.000604	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS3—Behcet's disease	1.39e-05	0.000592	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOB—Behcet's disease	1.37e-05	0.000586	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NOS3—Behcet's disease	1.16e-05	0.000496	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—Behcet's disease	1.13e-05	0.000482	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOB—Behcet's disease	1.1e-05	0.000468	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOA1—Behcet's disease	1.09e-05	0.000464	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—Behcet's disease	8.71e-06	0.000372	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOA1—Behcet's disease	8.67e-06	0.00037	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOB—Behcet's disease	8.46e-06	0.000361	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NOS3—Behcet's disease	8.23e-06	0.000352	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOA1—Behcet's disease	6.69e-06	0.000286	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NOS3—Behcet's disease	6.57e-06	0.000281	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NOS3—Behcet's disease	5.07e-06	0.000217	CbGpPWpGaD
